New Zealand markets closed

Royalty Pharma plc (RPRX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
39.13-0.34 (-0.86%)
At close: 04:00PM EST
39.13 0.00 (0.00%)
After hours: 05:21PM EST
Currency in USD

Valuation measures4

Market cap (intra-day) 16.22B
Enterprise value 20.62B
Trailing P/E 19.57
Forward P/E 11.60
PEG ratio (5-yr expected) N/A
Price/sales (ttm)9.17
Price/book (mrq)2.80
Enterprise value/revenue 9.02
Enterprise value/EBITDA 11.89

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 3-21.55%
S&P500 52-week change 317.58%
52-week high 352.98
52-week low 334.86
50-day moving average 339.87
200-day moving average 339.99

Share statistics

Avg vol (3-month) 32.24M
Avg vol (10-day) 32.15M
Shares outstanding 5429.51M
Implied shares outstanding 6607.17M
Float 8322.64M
% held by insiders 116.30%
% held by institutions 162.15%
Shares short (30 Dec 2021) 45.85M
Short ratio (30 Dec 2021) 42.72
Short % of float (30 Dec 2021) 41.86%
Short % of shares outstanding (30 Dec 2021) 41.36%
Shares short (prior month 29 Nov 2021) 45.91M

Dividends & splits

Forward annual dividend rate 40.76
Forward annual dividend yield 41.94%
Trailing annual dividend rate 30.66
Trailing annual dividend yield 31.67%
5-year average dividend yield 4N/A
Payout ratio 434.20%
Dividend date 314 Mar 2022
Ex-dividend date 416 Feb 2022
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2020
Most-recent quarter (mrq)29 Sep 2021


Profit margin 34.25%
Operating margin (ttm)72.46%

Management effectiveness

Return on assets (ttm)6.14%
Return on equity (ttm)15.40%

Income statement

Revenue (ttm)2.29B
Revenue per share (ttm)5.62
Quarterly revenue growth (yoy)8.80%
Gross profit (ttm)1.89B
Net income avi to common (ttm)782.92M
Diluted EPS (ttm)1.93
Quarterly earnings growth (yoy)-64.90%

Balance sheet

Total cash (mrq)2.11B
Total cash per share (mrq)4.92
Total debt (mrq)7.09B
Total debt/equity (mrq)68.27
Current ratio (mrq)10.88
Book value per share (mrq)13.49

Cash flow statement

Operating cash flow (ttm)2.09B
Levered free cash flow (ttm)-1.91B